Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

FDA Accepts New Drug Applications for Merck’s Doravirine, the Company’s Investigational Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), for Treatment of HIV-1 Infection

Editor's pick
Merck press release
8 January 2018
Resistance

Immediate HIV Treatment Has Little Impact on Risk of Future Drug Resistance

Editor's pick
The Body Pro
7 January 2018
How HIV works

Suboptimal ART adherence associated with greater inflammation in patients with HIV

Editor's pick
Healio
7 January 2018
Diabetes

Diabetes in people with HIV over 50 overwhelmingly linked to old antiretrovirals, not age or body weight

News
3 January 2018
New & experimental HIV treatments

HIV Drugs in the Pipeline: Expected Approvals for 2018

Editor's pick
Infectious Disease Special Edition
31 December 2017
Mental & emotional health problems

Study Finds Sustiva Not Strongly Linked to Suicidal Thoughts

Editor's pick
Poz
31 December 2017
New & experimental HIV treatments

Dolutegravir and lamivudine potent and safe in people starting HIV therapy for the first time

News
28 December 2017
HIV prevention policy

CDC Reportedly Bans Words Including “Transgender” and “Science-Based”

Editor's pick
Poz
19 December 2017
Treatment guidelines

NHS England have announced funding for immediate antiretroviral treatment for HIV patients

Editor's pick
Gay Times
19 December 2017
Adherence

Fixed-dose regimes ‘modestly’ lower risk of HIV treatment failure

Editor's pick
Avert
15 December 2017
Starting treatment

Baseline CD4 count biggest factor in long-term immune system improvements after starting HIV therapy

News
14 December 2017
Treatment outcomes & life expectancy

South Africa’s HIV treatment programme: a phoenix rising from the ashes?

Editor's pick
Ground Up
13 December 2017
Bad science & bogus treatments

Fingerprints of Russian Disinformation: From AIDS to Fake News

Editor's pick
New York Times
13 December 2017
Treatment guidelines

Transition to dolutegravir cost-effective in LMICs with high HIV drug resistance

Editor's pick
Healio
13 December 2017
Treatment simplification strategies

Could we safely reduce the frequency of treatments for HIV-positive people?

Editor's pick
The Conversation
8 December 2017
Resistance

HIV drug resistance now high enough to trigger a change in first-line treatment in eastern and southern Africa

News
4 December 2017
The search for a cure

HIV ‘cure’ based on one patient? Here’s what you need to know

Editor's pick
Health News Review
4 December 2017
Bad science & bogus treatments

Russia’s HIV epidemic is fuelled by virus deniers, who think it’s all a Western hoax

Editor's pick
South China Morning Post
4 December 2017
Health problems & ageing

Skin problems and HIV

About HIV
December 2017
Bad science & bogus treatments

Nigeria's flourishing 'miracle cure' business

Editor's pick
Pulse
1 December 2017
Resistance

Rising levels of HIV drug resistance

Editor's pick
Eurekalert Inf Dis
1 December 2017
Treatment outcomes & life expectancy

People living with HIV can live longer, but urgently need improved care to achieve better health outcomes and quality of life

Editor's pick
HIV Outcomes
29 November 2017
New & experimental HIV treatments

FDA Approves Juluca, the First Two-Drug HIV Regimen

Editor's pick
Poz
22 November 2017
HIV treatment

Top 10 HIV Clinical Developments of 2017

Editor's pick
The Body Pro
19 November 2017